Tumor CyTOF and histology showed T-cell and microglial enrichment in SB28 but not GL261 after Apoa1 or Il1b gene therapy treatments (Fig. 5d, Extended Data Fig. 5b). This evidence concerns the gene APOA1 and neoplasm.